Fake Drug Kills at Least Nine in China
Posted on: Monday, 22 May 2006, 06:04 CDT
At least nine people have died in southern China after being injected with a fake drug sold by a Chinese pharmaceutical company, hospital sources said Monday.
The nine died from kidney failure after receiving injections of a drug labeled Armillarisni A at a hospital affiliated with Sun Yat-Sen University in the southern city of Guangzhou, Xinhua reported.
The article said the deaths of nine other patients who received the same injection had not been conclusively linked to the drug. Another five remained in the hospital.
Officials closed down the producer of the drug, Qiqihar No. 2 Pharmaceutical Co., in the northern province of Heilongjiang, after the first deaths came to light.
An investigation showed that the pharmaceutical company had ordered propylene glycol from a drug supplier in September 2005, but the product delivered turned out to be diglycol, an industrial substance that causes acute kidney failure if taken by humans.
The error was not discovered, and the Armillarisni A was manufactured with the dangerous substance.
Xinhua did not say how many patients in other hospitals around the country had been affected.
Source: United Press International
Related Articles
- Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States
- Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R)
- Capella Healthcare Acquires Nine Hospitals
- Capella Healthcare to Purchase Nine Hospitals From Community Health Systems, Inc.
- Cumberland Pharmaceuticals Acquires Hospital Sales Force
- MS Drug Tysabri Cuts Hospital Stays
- Fake Chinese drug kills nine
- 340B Prime Vendor Program Adds NitroMed, Inc. To Growing List of Companies Providing Low-Cost Drugs to Clinics, Hospitals and Programs for Low-Income Americans
- Study: Drugs Contribute to Hospital Visits
- Malawi Official Blames "Funny Tender" for Drug Shortage in Hospitals
 |
 |
User Comments (0)
RSS Feeds